Orrick’s Munich office resides in one of the most significant emerging company markets in Europe, and our exceptional emerging company practice positions Orrick as a leading U.S.-German firm with significant global capabilities across Europe and Asia, serving clients in the biotechnology/life sciences and IT/Internet sectors as well as the renewable energies, clean tech and software sectors.
Our distinctive private equity/investment funds practice represents venture capital firms in their investments and exits with respect to their portfolio companies. Additionally, we serve as outside general counsel to the Venture Capital’s portfolio companies. Our office is recognized by JUVE for its “technology oriented VC expertise.”
In addition to our extensive experience as an emerging companies-focused corporate, investment funds, capital markets and Mergers & Acquisitions practice, we have built a substantial traditional corporate practice that is highly focused on the IT, telecom, media and life sciences/biotech industries.
Our Munich lawyers also offer litigation, employment, tax and IP/IT services that support our practices. For example, with a large portion of German and European IP litigation focused in Munich, our IP/IT team concentrates on the areas of copyright, licensing, unfair competition and trademark law.
Please visit our Germany Practice or de.orrick.com for more information.
- Mergers & Acquisitions/Corporate
- Emerging Companies
- Mergers and Acquisitions
- Capital Markets
- Private Investment Funds Group
- Intellectual Property